Progress with antiviral agents.
D000256:Adenoviridae / Q000187:drug effects; D000998:Antiviral Agents / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000494:pharmacology; D004267:DNA Viruses / Q000187:drug effects / Q000378:metabolism; D004269:DNA, Bacterial / Q000096:biosynthesis; D004357:Drug Synergism; D029822:Enterovirus B, Human / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism; D005467:Floxuridine / Q000494:pharmacology; D006564:Herpesviridae / Q000187:drug effects; D009705:Nucleosides / Q000494:pharmacology; D009711:Nucleotides / Q000494:pharmacology; D027383:Papillomaviridae / Q000187:drug effects; D027382:Polyomaviridae; D011684:Purine Nucleosides / Q000494:pharmacology; D012367:RNA, Viral / Q000096:biosynthesis; D018894:Reverse Transcriptase Inhibitors; D013329:Structure-Activity Relationship; D013844:Thiazoles / Q000494:pharmacology; D014721:Vesicular stomatitis Indiana virus / Q000187:drug effects / Q000378:metabolism; D014764:Viral Proteins / Q000096:biosynthesis
D000998:Antiviral Agents; D004269:DNA, Bacterial; D009705:Nucleosides; D009711:Nucleotides; D011684:Purine Nucleosides; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D013844:Thiazoles; D014764:Viral Proteins; D005467:Floxuridine; D001973:Bromodeoxyuridine